Encompass Health Corp
About Encompass Health Corp
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $5.9B
- Net income
- $566.2M
- Total assets
- $7.1B
- Market cap
- $10.3B
- Operating margin
- 17.7%
- Net margin
- 12.8%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $5.9B
- Operating expenses
- $4.9B
- Operating income
- $1.1B
- Income tax
- $192.9M
- Net income
- $759.1M
- EPS (basic)
- $5.62
- EPS (diluted)
- $5.54
Balance sheet
- Total assets
- $7.1B
- Current assets
- $905.9M
- Total liabilities
- $3.8B
- Current liabilities
- $836.4M
- Shareholders’ equity
- $3.2B
Cash flow
- Operating cash flow
- $1.2B
- Investing cash flow
- -$764.6M
- Financing cash flow
- -$431.2M
- Net cash flow
- -$21.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $10.3B
- P/E ratio
- 18.3
- EPS (diluted)
- $5.54
- Dividend yield
- 0.75%
- Shares outstanding
- 102.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 13, 1989
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $566.2M in FY2025.
- Revenue grew 16% from FY2021 to FY2025.
- Trading 20% below its 52-week high.
- Pays a dividend yielding about 0.75% annually.
- Valued at a price-to-earnings (P/E) ratio of 18.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Encompass Health Corp.
Write a review
News about Encompass Health Corp
News & sentiment via Polygon.io
